Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021

SELL
$441.0 - $508.24 $555,219 - $639,874
-1,259 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$439.85 - $518.83 $2.39 Million - $2.82 Million
-5,429 Reduced 81.18%
1,259 $574,000
Q4 2020

Feb 02, 2021

BUY
$435.06 - $527.66 $1.67 Million - $2.03 Million
3,848 Added 135.49%
6,688 $3.12 Million
Q3 2020

Nov 03, 2020

SELL
$359.77 - $441.52 $4,677 - $5,739
-13 Reduced 0.46%
2,840 $1.25 Million
Q2 2020

Aug 05, 2020

SELL
$275.2 - $362.34 $127,142 - $167,401
-462 Reduced 13.94%
2,853 $1.03 Million
Q1 2020

May 08, 2020

SELL
$255.3 - $340.05 $1.31 Million - $1.75 Million
-5,138 Reduced 60.78%
3,315 $940,000
Q4 2019

Feb 06, 2020

SELL
$271.93 - $328.04 $44,324 - $53,470
-163 Reduced 1.89%
8,453 $2.75 Million
Q3 2019

Oct 29, 2019

SELL
$268.46 - $305.43 $40,537 - $46,119
-151 Reduced 1.72%
8,616 $2.51 Million
Q2 2019

Aug 07, 2019

SELL
$257.51 - $295.55 $113,819 - $130,633
-442 Reduced 4.8%
8,767 $2.57 Million
Q1 2019

May 03, 2019

SELL
$212.17 - $273.72 $53,042 - $68,430
-250 Reduced 2.64%
9,209 $2.52 Million
Q4 2018

Feb 04, 2019

SELL
$208.47 - $251.98 $30,228 - $36,537
-145 Reduced 1.51%
9,459 $2.12 Million
Q3 2018

Nov 01, 2018

SELL
$205.57 - $244.32 $82,228 - $97,728
-400 Reduced 4.0%
9,604 $2.34 Million
Q2 2018

Aug 07, 2018

SELL
$203.14 - $219.53 $144,432 - $156,085
-711 Reduced 6.64%
10,004 $2.07 Million
Q1 2018

May 07, 2018

SELL
$192.98 - $224.11 $104,981 - $121,915
-544 Reduced 4.83%
10,715 $2.21 Million
Q4 2017

Feb 05, 2018

SELL
$182.03 - $200.37 $114,678 - $126,233
-630 Reduced 5.3%
11,259 $2.14 Million
Q3 2017

Nov 03, 2017

BUY
$171.74 - $194.04 $2.04 Million - $2.31 Million
11,889
11,889 $2.25 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $196B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.